As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 3/24/20  Outlook Therapeutics, Inc.        8-K:1,3,5,9 3/19/20    2:51K                                    Toppan Merrill/FA        
 1/31/20  Outlook Therapeutics, Inc.        8-K:1,3,5,8 1/27/20    8:520K                                   Toppan Merrill/FA        
12/23/19  Outlook Therapeutics, Inc.        8-K:1,2,3,812/20/19    5:229K                                   Toppan Merrill/FA        
 3/18/19  Outlook Therapeutics, Inc.        8-K:3,5,9   3/15/19    3:41K                                    Toppan Merrill/FA        
 1/22/19  Outlook Therapeutics, Inc.        8-K:3,8,9   1/22/19    3:66K                                    Toppan Merrill/FA        
 11/9/18  Outlook Therapeutics, Inc.        8-K:1,2,3,8 11/5/18    5:448K                                   Toppan Merrill/FA        
 7/19/18  Outlook Therapeutics, Inc.        8-K:1,3,5,8 7/18/18    5:368K                                   Toppan Vite NY Inc./FA   
  2/9/18  Outlook Therapeutics, Inc.        8-K:3,8,9    2/9/18    3:61K                                    Toppan Vite NY Inc./FA   
 9/11/17  Outlook Therapeutics, Inc.        8-K:1,2,3,5  9/7/17   13:1.4M                                   Toppan Merrill/FA        
  2/6/17  Outlook Therapeutics, Inc.        8-K:3,8,9    2/6/17    3:48K                                    Toppan Vite NY Inc./FA   
12/23/16  Outlook Therapeutics, Inc.        8-K:1,2,3,812/22/16    5:460K                                   Toppan Vite NY Inc./FA   

____________
¹	Filing/Form Type:  -K
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.